134 related articles for article (PubMed ID: 17124715)
1. Computer-aided rational design of catalytic antibodies: The 1F7 case.
Martí S; Andrés J; Silla E; Moliner V; Tuñón I; Bertrán J
Angew Chem Int Ed Engl; 2007; 46(1-2):286-90. PubMed ID: 17124715
[No Abstract] [Full Text] [Related]
2. Just a near attack conformer for catalysis (chorismate to prephenate rearrangements in water, antibody, enzymes, and their mutants).
Hur S; Bruice TC
J Am Chem Soc; 2003 Sep; 125(35):10540-2. PubMed ID: 12940735
[TBL] [Abstract][Full Text] [Related]
3. Determination of the stereochemistry of 2-succinyl-5-enolpyruvyl-6-hydroxy-3- cyclohexene-1-carboxylate, a key intermediate in menaquinone biosynthesis.
Jiang M; Chen M; Cao Y; Yang Y; Sze KH; Chen X; Guo Z
Org Lett; 2007 Nov; 9(23):4765-7. PubMed ID: 17956107
[TBL] [Abstract][Full Text] [Related]
4. On-the-path random walk sampling for efficient optimization of minimum free-energy path.
Chen M; Yang W
J Comput Chem; 2009 Aug; 30(11):1649-53. PubMed ID: 19462399
[TBL] [Abstract][Full Text] [Related]
5. The near attack conformation approach to the study of the chorismate to prephenate reaction.
Hur S; Bruice TC
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12015-20. PubMed ID: 14523243
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of active-site residues in chorismate mutase catalysis from molecular-dynamics simulations.
Guo H; Cui Q; Lipscomb WN; Karplus M
Angew Chem Int Ed Engl; 2003 Apr; 42(13):1508-11. PubMed ID: 12698486
[No Abstract] [Full Text] [Related]
7. How an enzyme surmounts the activation energy barrier.
Schowen RL
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):11931-2. PubMed ID: 14530397
[No Abstract] [Full Text] [Related]
8. Mutational biosynthesis of a FK506 analogue containing a non-natural starter unit.
Ban YH; Lee JH; Gu GR; Lee B; Mo S; Kwon HJ; Yoon YJ
Mol Biosyst; 2013 May; 9(5):944-7. PubMed ID: 23223556
[TBL] [Abstract][Full Text] [Related]
9. Multiple-steering QM-MM calculation of the free energy profile in chorismate mutase.
Crespo A; Martí MA; Estrin DA; Roitberg AE
J Am Chem Soc; 2005 May; 127(19):6940-1. PubMed ID: 15884923
[TBL] [Abstract][Full Text] [Related]
10. Menaquinone biosynthesis in Escherichia coli: identification of 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate as a novel intermediate and re-evaluation of MenD activity.
Jiang M; Cao Y; Guo ZF; Chen M; Chen X; Guo Z
Biochemistry; 2007 Sep; 46(38):10979-89. PubMed ID: 17760421
[TBL] [Abstract][Full Text] [Related]
11. Toward bifunctional antibody catalysis.
Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
[TBL] [Abstract][Full Text] [Related]
12. Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
J Phys Chem A; 2006 Jan; 110(2):726-30. PubMed ID: 16405346
[TBL] [Abstract][Full Text] [Related]
13. Binding and catalysis: a thermodynamic study on a catalytic antibody system.
Wade H; Scanlan TS
Chembiochem; 2003 Jun; 4(6):537-40. PubMed ID: 12794866
[No Abstract] [Full Text] [Related]
14. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
Teraishi K; Saito M; Fujii I; Nakamura H
J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
[TBL] [Abstract][Full Text] [Related]
15. Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process.
Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
Chemistry; 2008; 14(2):596-602. PubMed ID: 17960540
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric synthesis of the putative structure of (-)-oryzoxymycin.
Bunnage ME; Ganesh T; Masesane IB; Orton D; Steel PG
Org Lett; 2003 Feb; 5(3):239-42. PubMed ID: 12556161
[TBL] [Abstract][Full Text] [Related]
17. Comparison of chiral and racemic forms of zinc cyclohexane trans-1,2-dicarboxylate frameworks: a structural, computational, and calorimetric study.
Bailey AJ; Lee C; Feller RK; Orton JB; Mellot-Draznieks C; Slater B; Harrison WT; Simoncic P; Navrotsky A; Grossel MC; Cheetham AK
Angew Chem Int Ed Engl; 2008; 47(45):8634-7. PubMed ID: 18833555
[No Abstract] [Full Text] [Related]
18. Gold(I)-catalyzed 5-endo hydroxy- and alkoxycyclization of 1,5-enynes: efficient access to functionalized cyclopentenes.
Buzas AK; Istrate FM; Gagosz F
Angew Chem Int Ed Engl; 2007; 46(7):1141-4. PubMed ID: 17163559
[No Abstract] [Full Text] [Related]
19. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
Johnson G; Moore SW
J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
[TBL] [Abstract][Full Text] [Related]
20. De novo synthesis of (+)-isofregenedol.
Riou M; Barriault L
J Org Chem; 2008 Sep; 73(18):7436-9. PubMed ID: 18698826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
